The list of biomarkers for Long COVID available now and possible new ones on the horizon.
⭐Long Covid is a distinct disease.
🧪Before HIV had a test it resembled MECFS. Alot of people died. Now it must be ruled out by the HIV test before MECFS can be diagnosed. The same should happen for LC. We are watching people around the world take their own lives because this isn't being done properly. We could easily have tests and treatments but the money is spent on studies that are not helpful. Patients need awareness.
⌛The Now List (Unique to LC)
👉 Circulating Spike & Viral RNA (Simoa & ddPCR): Ultra-sensitive Single-Molecule Array (Simoa) assays detect persistent full-length SC2 Spike, S1 subunit, and N proteins in plasma, frequently packaged inside extracellular vesicles. Digital droplet PCR (ddPCR) quantifies low-copy viral RNA fragments in biofluids.
👉 Intracellular Monocyte & Platelet Reservoirs: Mass-spectrometric and flow-cytometric identification of SC2 Spike protein persisting inside long-lived non-classical monocytes (CD14+ CD16+) and megakaryocyte-derived circulating platelets.
👉 Terminal Complement Cascade Hyperactivation (C5b\text{-}9 & C4d): Persistent, elevated levels of membrane attack complexes (C5b\text{-}9), C4d, and altered C7 cleavage products in resting blood. This confirms active, continuous complement-mediated endotheliitis (Cervia-Hasler et al., Science).
👉 Matrix Destruction & Endothelial Activation (MMP-9 & sVCAM-1): Elevated Matrix Metalloproteinase-9 (MMP-9) and an altered MMP-9/TIMP-1 ratio, alongside elevated soluble vascular cell adhesion molecule-1 (sVCAM-1) and VEGF, signaling active basement membrane breakdown and microvascular starvation.
👉 Resistant Amyloid Microclots: Fluorescence microscopy (Thioflavin-S) and viscoelastic testing (TEG) identifying hyper-dense, fibrinolytic-resistant microclots rich in Alpha-2 Antiplasmin and Platelet Factor 4 (PF4), enmeshed with Neutrophil Extracellular Traps (NETs).
👉 Endocrine & T-Cell Exhaustion Panels: Severely blunted morning salivary/serum cortisol paired with high expression of T-cell exhaustion markers (PD-1, TIM-3, TIGIT) on virus-specific CD8+ T cells.
🥾The Tests Being Explored
PolyBio (led by Dr. Amy Proal and the LC Research Consortium) operates on the principle that standard peripheral blood draws miss the central pathology. Their diagnostic pipeline focuses on identifying viral reservoirs, tissue remodeling, and neuro-immune activation directly inside tissue sanctuaries and specialized biofluids.
1. Tissue-Level & Spatial Biomarker Mapping
👉Spatial Metabolomic Mapping (MALDI Mass Spectrometry Imaging): Directly mapping hundreds of lipids and metabolites at single-cell resolution across gut tissue, bone marrow, and muscle biopsies. This technique aligns localized metabolic failure and oxidative stress directly with single- and double-stranded SC2 tissue RNA.
👉 Tissue Biopsy Reservoirs (Gut, Reproductive Tract, Vagus Nerve):
Spatial transcriptomics and digital pathology documenting persistent viral RNA/protein in gastrointestinal mucosa, female reproductive tissues, and vagus nerve tissue, accompanied by localized mast cell degranulation.
👉 MENSA & Plasmablast "Immune Snapshots": Measuring Memory B-cell and antibody-secreting plasmablast activity (via Media Educated from Neural Tissue / MENSA assays) to prove that local B-cells are actively manufacturing fresh antibodies in response to an ongoing tissue viral reservoir.
2. Advanced Biofluid & Vesicle Tracking
👉 Single-Particle Extracellular Vesicle & Particle Analysis: Isolating EVPs from blood to capture protected viral cargo (dsRNA, Spike, envelope proteins) that the virus uses to travel through circulation without being neutralized by surface antibodies.
👉 Urinary Extracellular Vesicles (uEVs):
Analyzing uEVs as a non-invasive window into central neuro-immune activity, renal/systemic microvascular stress, and co-pathogen signatures.
1/2 Continue